You’ve got a game-changing product. They want to back innovators like you. What’s the secret to a happy marriage? More importantly, how to you get a first date?Recorded during OIS Retina@ASRS in San Antonio, Texas, five pharma and finance leaders discuss their current areas of interest, how to secure crucial series A funding, and what’s on the verge of disruption.Tune in today to discover:What’s hot in retina: Dr. Guerard believes multiple compounds can co-exist in the market. A researcher with a great science-backed idea may only need five to ten percent of the market share to build a valuable company. Think niche markets like uveitis; a delivery model for anti-VEGF therapies that lowers patient burden, and gene therapies with clear targets and strong preclinical studies.Advice for early-stage companies: It takes more than great technology to secure funding. Entrepreneurs must have a well-planned roadmap and a solid team, Menzo says. What should that roadmap include? Tune in.Advice for later-stage companies: Dr. Guerard discusses the area where most startups fall short, while Dr. Rahhal advises on how to move to the next inflection point.Other topics covered:How and when to go public? SPAC or reverse merger or IPO?Corporate partnerships: how do you use regional partnerships as funding vehicles and to successfully navigate complex regulatory and reimbursement environments?What’s the next disruptor in retina?The podcast lineup includes:Emmett T. Cunningham Jr., MD, PhD, MPH, senior managing director at Blackstone Life Sciences (moderator)Fred Guerard, PharmD, CEO of Graybug VisionTsuyoshi (Josh) Chiwata, director of venture management for Santen VenturesAndrew Liu, vice president of global corporate development for Chengdu Kanghong Pharmaceutical GroupJason Menzo chief operating officer for Foundation Fighting BlindnessFiras M. Rahhal, MD, a partner at ExSight Ventures, senior partner at Retina-Vitreous Associates Medical Group in Los Angeles, and associate clinical professor of ophthalmology at UCLA Geffen School of MedicineHit “Play” to Listen.